1996
DOI: 10.1016/s0014-2999(96)00797-2
|View full text |Cite
|
Sign up to set email alerts
|

The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
17
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 9 publications
1
17
0
Order By: Relevance
“…The Y 4 subtype is characterized by its high affinity for PPs and GR231118 (as an agonist; Michel et al, 1998). The Leu 31 Pro 34 -substituted analogs of NPY and PYY are also potent agonists on the Y 4 subtype (Gehlert et al, 1996). This receptor subtype can be activated by PYY and NPY, but with much lower potencies than the PPs (Lundell et al, 1995 , and hPP display potent agonist activities, whereas NPY(13-36), PYY(13-36), rPP, and GR231118 are much less active (Michel et al, 1998;Dumont et al, 2004a (Cabrele et al, 2001).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The Y 4 subtype is characterized by its high affinity for PPs and GR231118 (as an agonist; Michel et al, 1998). The Leu 31 Pro 34 -substituted analogs of NPY and PYY are also potent agonists on the Y 4 subtype (Gehlert et al, 1996). This receptor subtype can be activated by PYY and NPY, but with much lower potencies than the PPs (Lundell et al, 1995 , and hPP display potent agonist activities, whereas NPY(13-36), PYY(13-36), rPP, and GR231118 are much less active (Michel et al, 1998;Dumont et al, 2004a (Cabrele et al, 2001).…”
Section: Resultsmentioning
confidence: 99%
“…These results were confirmed using the Y 5 receptor antagonist CGP71683A (Dumont et al, 2000a). However, under these assay conditions, the possible recognition of the Y 4 subtype could not be fully excluded because [Leu 31 ,Pro 34 ]PYY is known to possess nanomolar affinity for this receptor (Gehlert et al, 1996). It is interesting that, using purported Y 4 ligands such as 125 I-hPP, 125 I-rPP, and 125 I-labeled bovine PP, we were able to visualize a very discrete distribution of specific receptor sites with moderate to very high amounts seen in a few regions, including the medial preoptic area, paraventricular nucleus of the hypothalamus, and interpeduncular nucleus (Trinh et al, 1996;Gehlert et al, 1997).…”
mentioning
confidence: 91%
“…Using [ 125 I]‐[Leu 31 ,Pro 34 ]‐PYY in the presence of selective non‐peptide Y 1 receptor antagonists, we were able to demonstrate that [ 125 I]‐[Leu 31 ,Pro 34 ]‐PYY/BIBP3226‐insensitive sites have a ligand binding profile similar to the Y 5 receptor subtype in the rat CNS (Dumont et al ., 1998a). However, under these conditions, the possible labelling of putative Y 4 receptor could not be fully excluded as [ 125 I]‐[Leu 31 ,Pro 34 ]‐PYY also possesses some affinity for this subtype (Gehlert et al ., 1996a). Interestingly, the present study demonstrated that [ 125 I]‐GR231118 binds with very high affinity to the Y 1 and Y 4 receptors, but not to the Y 2 and Y 5 subtypes, transfected in HEK293 cells.…”
Section: Discussionmentioning
confidence: 99%
“…However, none of the synthetic agonists used thus far demonstrated high selectivity for a single receptor subtype. In fact, [ 125 I]‐[Leu 31 ,Pro 34 ]‐PYY, first developed as a Y 1 agonist radioligand (Dumont et al ., 1995), was later demonstrated to bind with high affinity to the Y 4 (Gehlert et al ., 1996a,1996b; 1997) and Y 5 (Dumont et al ., 1998a; Gerald et al ., 1996) receptors. Similarly, [ 125 I]‐PYY 3–36 originally proposed as a Y 2 receptor probe (Dumont et al ., 1995) was found to also bind to the Y 5 (Gerald et al ., 1996) and possibly y 6 (Matsumoto et al ., 1996) subtypes.…”
Section: Introductionmentioning
confidence: 99%
“…Because PYY has very low affinity for rat Y4, iodinated pancreatic polypeptide was used as a radioligand in its characterisation. The Y4 receptor has been extensively studied by different groups using both iodinated PYY, pancreatic polypeptide and LP-NPY (Gehlert et al 1996b, c, 1997, Gregor et al 1996, Voisin et al 2000, Parker et al 2001. Depending on the radioligand used, different affinities have been reported for the ligands in the various studies.…”
Section: Discussionmentioning
confidence: 99%